The prevalence of cardiovascular disease in non-communicating hydrocephalus

Per Kristian Eide1, Are Hugo Pripp2

  • 1Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

Insights

Cardiovascular disease is more common in patients with non-communicating hydrocephalus (HC). This suggests a link between cardiovascular issues and the development of non-communicating HC, with diabetes also associated with abnormal intracranial pressure.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Non-communicating hydrocephalus (HC) results from blocked cerebrospinal fluid (CSF) pathways.
  • The relationship between cardiovascular disease (CVD) prevalence in non-communicating HC patients and the general population is not well-established.

Purpose of the Study:

  • To compare the prevalence of CVD in non-communicating HC patients versus a general population control group.
  • To investigate CVD prevalence in non-communicating HC patients compared to communicating hydrocephalus (idiopathic normal pressure hydrocephalus, iNPH) patients.

Main Methods:

  • Retrospective analysis of 50 non-communicating HC cases.
  • Comparison with a general control population (HUNT3 Survey, n=35,413) and iNPH patients (n=176).
  • Assessment of CVD prevalence including arterial hypertension, angina pectoris, cardiac infarction, and diabetes.

Main Results:

  • Increased prevalence of arterial hypertension (males), cardiac infarction (females), and diabetes (females) in non-communicating HC patients compared to the HUNT3 cohort.
  • No significant difference in overall CVD prevalence between non-communicating HC and iNPH patients.
  • Elevated diabetes prevalence in both non-communicating HC and iNPH patients with abnormal pulsatile intracranial pressure (ICP).

Conclusions:

  • A significantly higher prevalence of CVD exists in non-communicating HC, suggesting an association with its development.
  • Diabetes is linked to abnormal pulsatile ICP in both non-communicating HC and iNPH.
  • Findings indicate a potential shared pathophysiology or risk factors between CVD and non-communicating HC.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
705
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
484
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
936